COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1401: Articles 14001-14010  | Next

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
Eden, J.-S., Sikazwe, C., Xie, R., Deng, Y.-M., Sullivan, S. G., Michie, A., Levy, A., Cutmore, E., Blyth, C. C., Britton, P. N., Crawford, N., Dong, X., Dwyer, D. E., Edwards, K. M., Horsburgh, B. A., Foley, D., Kennedy, K., Minney-Smith, C., Speers, D., Tulloch, R. L., Holmes, E. C., Dhanasekaran, V., Smith, D. W., Kok, J., Barr, I. G.
10.1101/2021.07.21.21260810 — Posted: 2021-07-24
Severity of SARS-CoV-2 reinfections in second wave determines likelihood of mild endemicity
Lavine, J. S., Bjornstad, O. N., Coombs, D., Antia, R.
10.1101/2021.07.21.21260944 — Posted: 2021-07-24
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
Khan, H., Winstone, H., Jimenez-Guardeno, J., Graham, C., Doores, K., Goujon, C., Matthews, D., Davidson, A., Rihn, S., Palmarini, M., Neil, S., Malim, M.
10.1101/2021.07.23.453488 — Posted: 2021-07-23
US Dog Importations during the COVID-19 Pandemic: Do we have an erupting problem?
Pieracci, E. G., Williams, C., Wallace, R. M., Kalapura, C., Brown, C. M.
10.1101/2021.07.23.453524 — Posted: 2021-07-23
Improving RT-LAMP Detection of SARS-CoV-2 RNA through Primer Set Selection and Combination
Tanner, N., Zhang, Y.
10.1101/2021.07.23.453545 — Posted: 2021-07-23
Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in ferrets
Lehtinen, M., Kumar, R., Zabel, B., Makela, S. M., Nedveck, D., Tang, P., Latvala, S., Guery, S., Budinoff, C. R.
10.1101/2021.07.23.453521 — Posted: 2021-07-23
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
Alvarado, D. M., Son, J., Thackray, L. B., Diamond, M., Ding, S., Ciorba, M. A., Washington University IBD Investigators Group
10.1101/2021.07.23.453393 — Posted: 2021-07-23
The in vitro and in vivo potency of CT-P59 against Delta and its associated variants of SARS-CoV-2
Ryu, D.-K., Woo, H.-M., Kang, B., Noh, H., Kim, J.-I., Seo, J.-M., Kim, C., Kim, M., Kim, J.-W., Kim, N., Jeon, P., Lee, H., Yang, J.-S., Kim, K.-C., Lee, J.-Y., Lee, M.-H., Oh, S.-S., Chung, H.-Y., Kwon, K.-S., Lee, S.-Y.
10.1101/2021.07.23.453472 — Posted: 2021-07-23
Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.
Diez, J.-M., Romero, C., Gajardo, R.
10.1101/2021.07.23.453571 — Posted: 2021-07-23
Understanding the role of memory re-activation and cross-reactivity in the defense against SARS-CoV-2
Denninger, V., Xu, C. K., Meisl, G., Morgunov, A. S., Fiedler, S., Ilsley, A., Emmenegger, M., Malik, A. Y., Piziorska, M. A., Schneider, M. M., Devenish, S. R. A., Kosmoliaptsis, V., Aguzzi, A., Fiegler, H., Knowles, T. P. J.
10.1101/2021.07.23.453352 — Posted: 2021-07-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).